Gluten News and Research

RSS

Marker for inflammatory bowel disease linked to bipolar disorder

Researchers have found evidence that the gastrointestinal tract plays a role in the inflammatory pathology of bipolar disorder, suggesting the need to consider dietary modification and anti-inflammatory treatment for some patients.

12 Dec 2013

Expert offers tips for families to avoid sensory processing disorders during holiday travels

While holiday travels can be stressful for any family, the season presents greater challenges for families of children with sensory processing disorders. Varleisha Gibbs OTD, OTR/L, director of doctoral projects and assistant professor of occupational therapy at University of the Sciences in Philadelphia, said attempting to coordinate a child's sensory, dietary, and energy needs while traveling can make a holiday getaway seem like a full-time job.

26 Nov 2013

Research paper highlights experiences, results of celiac disease screening in young children

Most children who undergo screening to detect gluten intolerance, celiac disease, can handle it well. However, many people feel that the discovery of the disease and the treatment they receive does not provide a better quality of life.

16 Nov 2013

Scientists receive $2.2M grant to improve treatments for immune disorders, inflammatory diseases

Scientists from the Walter and Eliza Hall Institute have been awarded more than $2.2 million from the Australian Research Council (ARC) to improve treatments for immune disorders and inflammatory diseases.

16 Nov 2013

Gluten in the diet may modify intestinal microbiome, increasing incidences of Type 1 diabetes

Research has shown that the intestinal microbiome plays a large role in the development of Type 1 diabetes. Now, researchers at Mayo Clinic have demonstrated that gluten in the diet may modify the intestinal microbiome, increasing incidences of Type 1 diabetes. The research was published Nov. 13, in the journal PLOS ONE.

14 Nov 2013

BioLineRx obtains regulatory approval to initiate BL-7010 Phase 1/2 trial for celiac disease

BioLineRx, a biopharmaceutical development company, announced today that it has received regulatory approval from the Finnish National Supervisory Authority for Welfare and Health (Valvira) to commence a Phase 1/2 safety trial for BL-7010, for the treatment of celiac disease.

4 Nov 2013

Discovery provides additional key insights into the biology of Multiple Sclerosis

A Griffith University medical scientist is part of an international team which has made a key discovery in the effort to find the cause and cure of Multiple Sclerosis.

30 Sep 2013

Redd Remedies earns Better Nutrition Magazine's Best of Supplements Award for Gouch!

Redd Remedies, a leading provider of natural, condition-specific, health and wellness supplements, is this year's recipient of Better Nutrition Magazine's Best of Supplements Award with its all-natural, gluten-free Gouch!.

25 Sep 2013

BioLineRx announces regulatory submissions to commence Phase 1/2 trial for treatment of celiac disease

BioLineRx, a biopharmaceutical development company, announced today that it has filed the necessary regulatory submissions to commence a Phase 1/2 trial for BL-7010 - for the treatment of celiac disease - with the Finnish National Supervisory Authority for Welfare and Health (Valvira). The relevant ethics committee has already approved commencement of the study.

24 Sep 2013

International symposium to focus on celiac disease and gluten-related disorders

Preliminary results from a multinational project to study the impact of early childhood nutrition on celiac disease will be among the highlights of this month's 15th International Celiac Disease Symposium, hosted by the University of Chicago Medicine Celiac Disease Center.

23 Sep 2013

Coeliac disease on rise in Scots children

More children than ever before are living with a debilitating digestive disease, research has shown.

18 Sep 2013

Early respiratory infections linked to Type 1 diabetes

Researchers from Germany have found that respiratory infections in early life are linked to islet autoimmunity, implicating them as a potential risk factor in the development of Type 1 diabetes.

9 Sep 2013

BlueWater Seafoods’ Grill Fish products gets gluten free certification from GFCO

BlueWater Seafoods, a Canadian leader in frozen prepared seafood, is proud to announce that their Grill Fish line of products have been certified as gluten free by the Gluten-Free Certification Organization (GFCO), the leading gluten-free certification program in the world.

7 Sep 2013

Kate Farms announces personal endorsement deals with two professional athletes

Kate Farms, the creator of Komplete Ultimate Shakes, is excited to announce personal endorsement deals with professional auto racing driver,Tristan Nunez and undefeated professional boxer, Gabino Saenz. Komplete is the world's first vegan, dairy-free, gluten-free and soy-free ready to go drink meal replacement shake available in three flavors including Vanilla Bliss, Cocoa Fudge and Jav'a Latte and can be purchased nationally at The Vitamin Shoppe.

31 Aug 2013

Genetic analysis of intestinal bacteria shows Danes have 40% less gut bacteria genes

All people have trillions of bacteria living in their intestines. If you place them on a scale, they weigh around 1.5 kg. Previously, a major part of these 'blind passengers' were unknown, as they are difficult or impossible to grow in laboratories.

29 Aug 2013

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

Patients with celiac disease who had persistent intestine damage (identified with repeat biopsy) had a higher risk of lymphoma than patients whose intestines healed, according to findings published in the August 6, 2013, issue of Annals of Internal Medicine.

6 Aug 2013

Boulder Brands commends FDA's gluten-free labeling standards

Boulder Brands commends the U.S. Food and Drug Administration's decision today to standardize gluten-free labeling. Glutino and Udi's, Boulder Brands' gluten-free brands and trusted pioneers and leaders in gluten-free living, have spent years advocating for the FDA to create this mandate.

3 Aug 2013

Omission Brewing announces support for FDA's gluten-free labeling standard

Omission Brewing Company today announced support for the FDA's new gluten-free labeling standard as an important step forward in providing clear, consistent guidance to gluten sensitive consumers, including celiac disease sufferers. With the new labeling rules issued today, the FDA has officially adopted the widely accepted standard of 20 ppm gluten, which has been in place in many countries around the world for several years.

3 Aug 2013

FDA publishes new regulation defining "gluten-free" for food labeling to protect people with celiac disease

The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.

3 Aug 2013

Innovative manufacturing technologies increase demand for gluten-free foods

New technologies and ingredients are improving the taste, appearance and nutritional content of gluten-free food products, a market that is expected to grow to $6 billion by 2017, according to a presentation today at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- in Chicago.

18 Jul 2013

Gluten News and Research

Marker for inflammatory bowel disease linked to bipolar disorder

Expert offers tips for families to avoid sensory processing disorders during holiday travels

Research paper highlights experiences, results of celiac disease screening in young children

Scientists receive $2.2M grant to improve treatments for immune disorders, inflammatory diseases

Gluten in the diet may modify intestinal microbiome, increasing incidences of Type 1 diabetes

BioLineRx obtains regulatory approval to initiate BL-7010 Phase 1/2 trial for celiac disease

Discovery provides additional key insights into the biology of Multiple Sclerosis

Redd Remedies earns Better Nutrition Magazine's Best of Supplements Award for Gouch!

BioLineRx announces regulatory submissions to commence Phase 1/2 trial for treatment of celiac disease

International symposium to focus on celiac disease and gluten-related disorders

Coeliac disease on rise in Scots children

Early respiratory infections linked to Type 1 diabetes

BlueWater Seafoods’ Grill Fish products gets gluten free certification from GFCO

Kate Farms announces personal endorsement deals with two professional athletes

Genetic analysis of intestinal bacteria shows Danes have 40% less gut bacteria genes

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

Boulder Brands commends FDA's gluten-free labeling standards

Omission Brewing announces support for FDA's gluten-free labeling standard

FDA publishes new regulation defining "gluten-free" for food labeling to protect people with celiac disease

Innovative manufacturing technologies increase demand for gluten-free foods

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News